Teaching
External
David has supervised 15 Research Masters or PhD students to completion, and acted as examiner for over 40 PhD and MD examinations. He has also acted as external examiner for Pharmacy and Pharmacology degree schemes. David was recently external examiner for the Pharmacology degree schemes at the University of Aberdeen and the University of Cambridge, and is current external examiner for the University of Edinburgh.
Modules for 2026-27
Cancer Pharmacology for Medicinal Chemists
Module code: LIFE402
Role: Teaching
Cardiovascular and Respiratory Pharmacology
Module code: LIFE313
Role: Teaching
DRUG ACTION
Module code: LIFE206
Role: Teaching
MOLECULAR AND NEUROPHARMACOLOGY
Module code: LIFE317
Role: Teaching
NEUROPHARMACOLOGY
Module code: LIFE369
Role: Teaching
PHARMACOLOGY RESEARCH PROJECTS
Module code: PHAR660
Role: Teaching
Supervised Theses
- A study of the molecular pharmacological properties of C5a and C5a des Arg: defining their biased agonist profile and contrasting biological function
- CYCLOSPORINE BIOSYNTHESIS AND SELF-RESISTANCE IN FUNGI: TOWARD THE DISCOVERY AND DEVELOPMENT OF IMPROVED DRUG ANALOGS
- Clinical Understanding of the Molecular Mechanisms Behind Patient Pharmacogenetic-Mediated Drug Resistance Toxicity
- Developing a Lupus Nephritis urinary biomarker panel in children for use in a clinical trial (ABRIDGED VERSION)
- Developing a lupus nephritis urinary biomarker panel in children for use in a clinical trial
- Exploring the Comparative Networks of NFE2L Transcription Factors: Protein Interactions and Transcriptomic Insights
- Exploring the Role of Prostaglandin G/H Synthase Signalling in Chemoresistance in Acute Myeloid Leukaemia
- Exploring the Role of Targeting the PH Domain in BTK-Mediated Genes Expression within Mantle Cell Lymphoma Cells
- Functional maturation of human IPSC cardiomyocytes for increased predictivity of effects on contractility
- Gene editing of BTK using CRISPR/Cas9 to study drug resistance in acute myeloid leukaemia
- Investigating the Human NRF2 Network using CRISPR/Cas9 Gene Editing
- Investigating the Role of Extracellular-signal-regulated kinase 5 (ERK5) in Acute Myeloid Leukaemia cells and Quizartinib-resistant cells
- Investigation into the nature of drug and chemical antigens displayed on HLA
- Measuring functional differences between IgM, IgD and chemokine signaling (CXCR4/CXCL12) in mantle cell lymphoma cell lines using kinome profiling
- Repurpose of atovaquone for treatment of FLT3-ITD quizartinib sensitive and resistant acute myeloid leukemia
- The FLT3 tyrosine kinase receptor ITD mutation controls its expression and drug resistance in acute myeloid leukaemia
- The Role of NRAS in Acute Myeloid Leukaemia
- The chemokine regulation of Bruton's tyrosine kinase in acute myeloid leukaemia
- The role of NRF2 in Acute Myeloid Leukaemia (AML)